Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Tibolone and risk of gynecological hormone sensitive cancer
Ellen Christine Leth Løkkegaard
*
, Lina Steinrud Mørch
*
Corresponding author af dette arbejde
Institut for Klinisk Medicin
5
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Tibolone and risk of gynecological hormone sensitive cancer'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Tibolone
100%
Hormone-dependent Cancer
100%
Endometrial Cancer
80%
Confidence Interval
80%
Duration of Use
60%
Ovarian Cancer
60%
Incidence Rate
60%
Current Users
40%
Type I Endometrial Cancer
40%
Tumor
40%
Prospective Cohort Study
20%
Hormone-sensitive
20%
Estrogenic
20%
Estrogen Therapy
20%
Unopposed Estrogen
20%
Menopausal Hormone Therapy
20%
Estrogen
20%
Androgenic
20%
Poisson Regression Analysis
20%
Cancer Cases
20%
Increased Incidence
20%
Hormone Therapy
20%
Confounding Factors
20%
Progestin
20%
Synthetic Steroids
20%
Risk Increase
20%
Danish Registers
20%
Histology
20%
Ovarian Cancer Risk
20%
Medicine and Dentistry
Uterine Cancer
100%
Malignant Neoplasm
100%
Tibolone
100%
Ovarian Cancer
66%
Ovarian Tumor
50%
Neoplasm
33%
Hormone Therapy
33%
Estrogen Therapy
16%
Prospective Cohort Study
16%
Gestagen
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Tibolone
100%
Endometrium Cancer
100%
Ovary Cancer
66%
Ovary Tumor
50%
Endocrine Therapy
33%
Neoplasm
33%
Progestin
16%
Prospective Cohort Study
16%